Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients
CS Walti, C Stuehler, D Palianina… - Current Opinion in …, 2022 - journals.lww.com
Immunocompromised host section: Adoptive T-cell therapy for... : Current Opinion in
Infectious Diseases Immunocompromised host section: Adoptive T-cell therapy for dsDNA …
Infectious Diseases Immunocompromised host section: Adoptive T-cell therapy for dsDNA …
Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023
MY Sun, W Li, W Chen - Human Vaccines & Immunotherapeutics, 2023 - Taylor & Francis
Recently, the remarkable success of chimeric antigen receptor T cell (CAR-T) therapy in
treating certain tumors has led to numerous studies exploring its potential application to treat …
treating certain tumors has led to numerous studies exploring its potential application to treat …
What's New: Updates on Cytomegalovirus in Solid Organ Transplantation
AG Stewart, CN Kotton - Transplantation, 2024 - journals.lww.com
Cytomegalovirus (CMV) is one of the most common infections occurring after solid organ
transplantation. This high burden of disease, which incurs sizeable morbidity, may be …
transplantation. This high burden of disease, which incurs sizeable morbidity, may be …
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗ 03 and HLA-B∗ 15 via peptide-PRISM
AF Rein, CD Lauruschkat, I Muchsin, C Köchel… - Blood …, 2024 - ashpublications.org
Human cytomegalovirus (HCMV) reactivation poses a substantial risk to patients receiving
tranplants. Effective risk stratification and vaccine development is hampered by a lack of …
tranplants. Effective risk stratification and vaccine development is hampered by a lack of …
Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature
D Yang, Y Yao, Y Sun, E Jiang - Frontiers in Immunology, 2023 - frontiersin.org
In the absence of prophylactic therapy, cytomegalovirus (CMV) viremia is a common
complication following allogeneic hematopoietic cell transplantation (allo-HCT) and …
complication following allogeneic hematopoietic cell transplantation (allo-HCT) and …
[HTML][HTML] Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review
TFGS Bandeira, LC Marti, ET Rother, LR Correia… - Pharmaceutics, 2024 - mdpi.com
Cytomegalovirus (CMV) poses a significant threat to post-hematopoietic cell transplantation
(HCT). Control strategies include letermovir prophylaxis or ganciclovir pre-emptive therapy …
(HCT). Control strategies include letermovir prophylaxis or ganciclovir pre-emptive therapy …
[HTML][HTML] Cytomegalovirus Infections in Hematopoietic Stem Cell Transplant: Moving Beyond Molecular Diagnostics to Immunodiagnostics
Human CMV, regularly reactivated by simple triggers, results in asymptomatic viral
shedding, powerful cellular immune responses, and memory inflation. Immunocompetent …
shedding, powerful cellular immune responses, and memory inflation. Immunocompetent …
Eigenschaften und Charakterisierung von CD8 Treg im Zusammenhang mit einer Cytomegalovirus-Infektion
S Hamdan - 2022 - openscience.ub.uni-mainz.de
Regulatorische T-Zellen (Treg) können die Selbsttoleranz des Immunsystems regulieren,
indem sie die angeborene und adaptive Immunantwort supprimieren. Ihre spezifische Rolle …
indem sie die angeborene und adaptive Immunantwort supprimieren. Ihre spezifische Rolle …